Optical coherence tomography predictors of retinal pigment epithelial tear following intravitreal bevacizumab injection

Ophthalmic Surgery Lasers and Imaging

Volumn 40, Issue 6, 2009, Pages 570-575

  Moroz, Iris ^a   Moisseiev, Joseph ^a   Alhalel, Amir ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; OBSERVATIONAL STUDY; OPTICAL COHERENCE TOMOGRAPHY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA MACULA AGE RELATED DEGENERATION; RETINA TEAR; RETROSPECTIVE STUDY; RISK ASSESSMENT; SUBRETINAL NEOVASCULARIZATION;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CHOROIDAL NEOVASCULARIZATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS; MALE; PROGNOSIS; RETINAL PERFORATIONS; RETINAL PIGMENT EPITHELIUM; RETROSPECTIVE STUDIES; RISK FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITREOUS BODY;

EID: 72249105179     PISSN: 15428877     EISSN: None     Source Type: Journal    
DOI: 10.3928/15428877-20091030-06     Document Type: Article

References (22)

1. Chang LK, Sarraf D. Tears of the retinal pigment epithelium: an old problem in a new era. Retina. 2007;27:523-534. (Pubitemid 46905141)
2. Gass JDM. Retinal pigment epithelial rip during krypton laser photocoagulation. Am J Ophthalmol. 1984;98:700-706.
3. Gelisken F, Inhoffen W, Partsch M, Schneider U, Kressig I. Retinal pigment epithelial tear after photodynamic therapy for choroidal neovascularization. Am J Ophthalmol. 2001;131:518-520. (Pubitemid 32273446)
4. Pece A, Introini U, Bottoni F, Brancato R. Acute retinal pigment epithelial tear after photodynamic therapy. Retina. 2001;21:661-665. (Pubitemid 34027784)
5. Dhalla MS, Blinder KJ, Tewari A, Hariprasad SM, Apte RS. Retinal pigment epithelial tear following intravitreal pegaptanib sodium. Am J Ophthalmol. 2006;141:752-754.
6. Chan CK, Meyer CH, Gross JG, et al. Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration. Retina. 2007;27:541-551. (Pubitemid 46905143)
7. Gelisken F, Ziemssen F, Voelker M, Bartz-Schmidt KU. Retinal pigment epithelial tear following intravitreal bevacizumab injection for neovascular age-related macular degeneration. Acta Ophthalmol Scand. 2006;84:833-834. (Pubitemid 44688343)
8. Ronan SM, Yoganathan P, Chien FY, et al. Retinal pigment epithelium tears after intravitreal injections of bevacizumab (Avastin) for neovascular age-related macular degeneration. Retina. 2007;27:535-540. (Pubitemid 46905142)
9. Spandau UHM, Jonas JB. Retinal pigment epithelium tear after intravitreal bevacizumab for exudative age-related macular degeneration. Am J Ophthalmol. 2006;142:1068-1070. (Pubitemid 44853878)
10. Coscas G, Koening F, Soubrane G. The pretear characteristics of pigment epithelial detachments: a study of 40 eyes. Arch Ophthalmol. 1990;108:1687-1693.
11. Shiraki K, Kohono T, Ataka S, Abe K, Inoue K, Miki T. Thinning and small holes at an impending tear of a retinal pigment epithelial detachment. Graefes Arch Clin Exp Ophthalmol. 2001;239:430-436. (Pubitemid 32694451)
12. Bakri SJ, Kitzmann AS. Retinal pigment epithelial tear after intravitreal ranibizumab. Am J Ophthalmol. 2007;143:505-507. (Pubitemid 46273349)
13. Carvounis PE, Kopel AC, Benz MS. Retinal epithelium tears following ranibizumab for exudative age-related macular degeneration. Am J Ophthalmol. 2007;143:504-505. (Pubitemid 46273342)
14. Gamulescu MA, Framme C, Sachs H. RPE-rip after intravitreal bevacizumab (Avastin) treatment for vascularised PED secondary to AMD. Graefes Arch Clin Exp Ophthalmol. 2007;245:1037-1040.
15. Meyer CH, Mennel S, Schmidt JC, Kroll P. Acute retinal pigment epithelial tear following intravitreal bevacizumab (Avastin) injection for occult neovascularisation secondary to age related macular degeneration. Br J Ophthalmol. 2006;90:1207-1208. (Pubitemid 44351161)
16. Shah CP, Hsu J, Garg SJ, Fischer DH, Kaiser R. Retinal pigment epithelial tear after intravitreal bevacizumab injection. Am J Ophthalmol. 2006;142:1070-1072. (Pubitemid 44853903)
17. Bressler NM, Finkelstein D, Sunness JS, Maguire AM, Yarian D. Retinal pigment epithelial tears through the fovea with preservation of good visual acuity. Arch Ophthalmol. 1990;108:1694-1697.
18. Yeo JH, Marcus S, Murphy RP. Retinal pigment epithelial tears: patterns and prognosis. Ophthalmology. 1988;95:8-13. (Pubitemid 18052396)
19. Krishan NR, Chandra SR, Stevens TS. Diagnosis and pathogenesis of retinal pigment epithelium tears. Am J Ophthalmol. 1985;100:698-707. (Pubitemid 16206941)
20. Giovannini A, Amato GP, Mariotti C, Scassaellati-Sforzolini B. OCT imaging of choroidal neovascularization and its role in the determination of patients' eligibility for surgery. Br J Ophthalmol. 1999;83:438-442. (Pubitemid 29161185)
21. Kook D, Wolf A, Neubauer AS, et al. Retinal pigment epithelial tears after intravitreal injections of bevacizumab for AMD: frequency and progress [article in German]. Ophthalmologe. 2008;105:158-164.
22. Garg S, Brod R, Kim D, Lane RG, Maguire J, Fischer D. Retinal pigment epithelial tears after intravitreal bevacizumab injection for exudative age-related macular degeneration. Clin Experiment Ophthalmol. 2008;36:252-256. (Pubitemid 351560274)